Overall, this longitudinal study supports the possibility that APOE ε4 carriers have altered trajectories of white matter and cognitive development in early childhood, and it continues to raise questions about the role of APOE in normal human brain development, the relevance of these developmental changes to the predisposition to AD, and how such brain changes early in life may lead to subsequent AD pathology. Here, APOE is linked to Alzheimer disease.